NCT01160341

Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism

Phase 4 Study of About the Effect of Testosterone Treatment on the Components of Metabolic Syndrome

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 312 (actual)
• Sponsor: Gulhane School of Medicine · Academic / Other
• Sex: Male
• Age: 18 Years – 26 Years
• Healthy volunteers: Accepted

Summary

The study is designed to answer the following questions: 1. Is hypogonadism a cause for the metabolic syndrome ? 2. What is the effect of testosterone replacement on the metabolic parameters ?

Detailed description

This is a retrospective design, which is performed by investigating the registrations of patients with hypogonadotrophic hypogonadism between the years 2002-2009.

Conditions

• Hypogonadism

Interventions

Type	Name	Description
DRUG	Testosteron	Testosteron 250mg injection per 3-4 weeks for 6 months

Timeline

• Start date: 2009-08-01
• Primary completion: 2010-01-01
• Completion: 2010-01-01
• First posted: 2010-07-12
• Last updated: 2010-07-12

Locations

1 site across 1 country: Turkey (Türkiye)